Australia, June 18 -- Axsome Therapeutics Inc., owns the trademark (2519628) for 'AXSOME' and 'WORD THRU MOLECULAR-DIAGRAM' till July 19, 2034.

Status: protected: Registered/protected

Classes: 5 [Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's di...